Clinical Features, Intensive Care Needs, and Outcome of Carbamazepine Poisoning in Children
© 2022. Dr. K C Chaudhuri Foundation..
Carbamazepine is commonly used antiseizure medication with a narrow therapeutic range. The data on carbamazepine poisoning in children from India is limited. In this retrospective study, the authors reported 10 children with carbamazepine poisoning admitted to pediatric intensive care unit (PICU) of a tertiary care teaching hospital in North India over a period of 8 y (2013 to 2020). The median age was 5.5 (4.3-6) y and 60% cases were males. All had accidental ingestion and the dose ingested was 96 (80-103) mg/kg. The common clinical features were drowsiness (100%), tachycardia (80%), vomiting (60%), seizures (60%), respiratory failure (60%), and dystonia (50%). At admission, 60% children had coma. The treatment included gastric lavage (70%), single-dose-activated charcoal (60%), multidose-activated charcoal (30%), mechanical ventilation (60%), and dialysis (20%). The duration of PICU and hospital stay was 36 (22-45) h and 48 (48-60) h, respectively. There was no mortality.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Indian journal of pediatrics - 89(2022), 10 vom: 11. Okt., Seite 1022-1024 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Takia, Lalit [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
16291-96-6 |
|---|
| Anmerkungen: |
Date Completed 20.09.2022 Date Revised 06.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12098-022-04155-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338085866 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338085866 | ||
| 003 | DE-627 | ||
| 005 | 20231225235856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12098-022-04155-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1126.xml |
| 035 | |a (DE-627)NLM338085866 | ||
| 035 | |a (NLM)35277811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Takia, Lalit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Features, Intensive Care Needs, and Outcome of Carbamazepine Poisoning in Children |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2022 | ||
| 500 | |a Date Revised 06.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. Dr. K C Chaudhuri Foundation. | ||
| 520 | |a Carbamazepine is commonly used antiseizure medication with a narrow therapeutic range. The data on carbamazepine poisoning in children from India is limited. In this retrospective study, the authors reported 10 children with carbamazepine poisoning admitted to pediatric intensive care unit (PICU) of a tertiary care teaching hospital in North India over a period of 8 y (2013 to 2020). The median age was 5.5 (4.3-6) y and 60% cases were males. All had accidental ingestion and the dose ingested was 96 (80-103) mg/kg. The common clinical features were drowsiness (100%), tachycardia (80%), vomiting (60%), seizures (60%), respiratory failure (60%), and dystonia (50%). At admission, 60% children had coma. The treatment included gastric lavage (70%), single-dose-activated charcoal (60%), multidose-activated charcoal (30%), mechanical ventilation (60%), and dialysis (20%). The duration of PICU and hospital stay was 36 (22-45) h and 48 (48-60) h, respectively. There was no mortality | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Activated charcoal | |
| 650 | 4 | |a Antiepileptic drugs | |
| 650 | 4 | |a Hemodialysis | |
| 650 | 4 | |a Poisoning | |
| 650 | 4 | |a Seizures | |
| 650 | 7 | |a Charcoal |2 NLM | |
| 650 | 7 | |a 16291-96-6 |2 NLM | |
| 650 | 7 | |a Carbamazepine |2 NLM | |
| 650 | 7 | |a 33CM23913M |2 NLM | |
| 700 | 1 | |a Kc, Sudeep |e verfasserin |4 aut | |
| 700 | 1 | |a Randhawa, Manjinder |e verfasserin |4 aut | |
| 700 | 1 | |a Angurana, Suresh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Nallasamy, Karthi |e verfasserin |4 aut | |
| 700 | 1 | |a Bansal, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Jayashree, Muralidharan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of pediatrics |d 1945 |g 89(2022), 10 vom: 11. Okt., Seite 1022-1024 |w (DE-627)NLM000070742 |x 0973-7693 |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2022 |g number:10 |g day:11 |g month:10 |g pages:1022-1024 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12098-022-04155-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 89 |j 2022 |e 10 |b 11 |c 10 |h 1022-1024 | ||